Krebs Biochemicals Price To Sales vs. Total Debt

KREBSBIO   110.17  3.43  3.02%   
Based on Krebs Biochemicals' profitability indicators, Krebs Biochemicals and may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Krebs Biochemicals' ability to earn profits and add value for shareholders.
For Krebs Biochemicals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Krebs Biochemicals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Krebs Biochemicals and utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Krebs Biochemicals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Krebs Biochemicals and over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Krebs Biochemicals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Krebs Biochemicals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Krebs Biochemicals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Krebs Biochemicals and Total Debt vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Krebs Biochemicals's current stock value. Our valuation model uses many indicators to compare Krebs Biochemicals value to that of its competitors to determine the firm's financial worth.
Krebs Biochemicals and is currently regarded as number one stock in price to sales category among its peers. It also is considered the number one company in total debt category among its peers making up about  511,357,258  of Total Debt per Price To Sales. Comparative valuation analysis is a catch-all model that can be used if you cannot value Krebs Biochemicals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Krebs Biochemicals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Krebs Total Debt vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Krebs Biochemicals

P/S

 = 

MV Per Share

Revenue Per Share

 = 
4.67 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Krebs Biochemicals

Total Debt

 = 

Bonds

+

Notes

 = 
2.39 B
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Krebs Total Debt vs Competition

Krebs Biochemicals and is considered the number one company in total debt category among its peers. Total debt of Health Care industry is now estimated at about 989.06 Billion. Krebs Biochemicals adds roughly 2.39 Billion in total debt claiming only tiny portion of equities under Health Care industry.
Total debt  Valuation  Capitalization  Revenue  Workforce

Krebs Biochemicals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Krebs Biochemicals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Krebs Biochemicals will eventually generate negative long term returns. The profitability progress is the general direction of Krebs Biochemicals' change in net profit over the period of time. It can combine multiple indicators of Krebs Biochemicals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income114.4 M120.2 M
Operating Income-152 M-159.6 M
Income Before Tax-197.3 M-207.1 M
Total Other Income Expense Net-45.3 M-47.6 M
Net Loss-197.3 M-207.1 M
Income Tax Expense67.5 M70.9 M
Net Loss-197.3 M-207.1 M
Net Loss-222.2 M-233.3 M
Interest Income34.2 M40.7 M
Net Interest Income-46.9 M-49.2 M
Change To Netincome58.8 M61.8 M

Krebs Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Krebs Biochemicals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Krebs Biochemicals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Krebs Biochemicals' important profitability drivers and their relationship over time.

Use Krebs Biochemicals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Krebs Biochemicals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will appreciate offsetting losses from the drop in the long position's value.

Krebs Biochemicals Pair Trading

Krebs Biochemicals and Pair Trading Analysis

The ability to find closely correlated positions to Krebs Biochemicals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Krebs Biochemicals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Krebs Biochemicals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Krebs Biochemicals and to buy it.
The correlation of Krebs Biochemicals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Krebs Biochemicals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Krebs Biochemicals and moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Krebs Biochemicals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Krebs Biochemicals position

In addition to having Krebs Biochemicals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials Thematic Idea Now

Financials
Financials Theme
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Krebs Stock

To fully project Krebs Biochemicals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Krebs Biochemicals and at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Krebs Biochemicals' income statement, its balance sheet, and the statement of cash flows.
Potential Krebs Biochemicals investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Krebs Biochemicals investors may work on each financial statement separately, they are all related. The changes in Krebs Biochemicals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Krebs Biochemicals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.